USA flag logo/image

An Official Website of the United States Government

Company Information:

Company Name:
CCL Biomedical Inc.
Address:
224 N. Washington Street
Havre de Grace, MD
Phone:
(410) 939-9356
URL:
N/A
EIN:
320013068
DUNS:
91905484
Number of Employees:
2
Woman-Owned?:
No
Minority-Owned?:
No
HUBZone-Owned?:
No

Commercialization:

Has been acquired/merged with?:
N/A
Has had Spin-off?:
N/A
Has Had IPO?:
N/A
Year of IPO:
N/A
Has Patents?:
N/A
Number of Patents:
N/A
Total Sales to Date $:
$ 0.00
Total Investment to Date $
$ 0.00
POC Title:
N/A
POC Name:
N/A
POC Phone:
N/A
POC Email:
N/A
Narrative:
N/A

Award Totals:

Program/Phase Award Amount ($) Number of Awards
SBIR Phase I $519,602.00 5
SBIR Phase II $463,713.00 1
STTR Phase I $99,977.00 1
STTR Phase II $500,000.00 1

Award List:

STTR Phase I: Engineering of Non-leaching Antibacterial Surfaces and Textiles

Award Year / Program / Phase:
2003 / STTR / Phase I
Award Amount:
$99,977.00
Agency:
NSF
Principal Investigator:
Nina Lamba
Research Institution:
University of Delaware
RI Contact:
N/A
Abstract:
This Small Business Technology Transfer (STTR) Phase I proposes to develop antibacterial surfaces and textiles for commercial applications. A series of novel potent dendrimer biocides has been identified, which can be used alone to kill microorganisms, or bound to polymer substrates to produce… More

Anti-Terrorism - Consequence Management and Recovery

Award Year / Program / Phase:
2003 / SBIR / Phase I
Award Amount:
$69,991.00
Agency / Branch:
DOD / NAVY
Principal Investigator:
Nina M. K. Lamba, Chief Operating Officer
Abstract:
The threat of terrorist or military attack using biological, chemical or radiological weapons is one of the largest concerns to U.S. military forces. Development of defense initiatives that can be implemented to neutralize agents and decontaminatepersonnel, equipment and buildings are required to… More

Polymers for Infection Resistant Urinary Catheters

Award Year / Program / Phase:
2003 / SBIR / Phase I
Award Amount:
$99,995.00
Agency:
HHS
Principal Investigator:
Abstract:
DESCRIPTION (provided by applicant): Hospital acquired infections are on the increase and compromise the quality and cost-effectiveness of health care. A significant number of device-associated infections occur with urinary catheters. New and effective strategies to supplement and complement… More

STTR Phase II: Engineering of Non-leaching Antibacterial Non-woven Textiles

Award Year / Program / Phase:
2006 / STTR / Phase II
Award Amount:
$500,000.00
Agency:
NSF
Principal Investigator:
Research Institution:
Univ of DE
RI Contact:
Joseph M. Deitzel
Abstract:
This Small Business Technology Transfer (STTR) Phase II project proposes the development of a unique family of biocidal polymers that have been shown to be non-leaching, and do not require regeneration or refreshment of activity. The Phase I study demonstrated the synthesis of these polymers… More

SBIR Phase I: Biocidal Textiles for Active Infection Control

Award Year / Program / Phase:
2007 / SBIR / Phase I
Award Amount:
$100,000.00
Agency:
NSF
Principal Investigator:
Abstract:
This Small Business Innovation Research (SBIR) Phase I project aims to develop a novel antimicrobial compound to provide active infection control to textiles that will be applied as a finishing treatment. Each year, 5-10% of individuals admitted to U.S. hospitals acquire an infection during… More

Biocidal Surfaces for Medical Hardware

Award Year / Program / Phase:
2008 / SBIR / Phase I
Award Amount:
$100,000.00
Agency:
HHS
Principal Investigator:
Abstract:
DESCRIPTION (provided by applicant): Each year, 5-10% of patients admitted to acute care hospitals in the United States (1.75- 3.5 million people) acquire an infection while in hospital. Consequences of hospital-acquired (nosocomial) infections include pro longed hospital stays, increased pain and… More

SBIR Phase II: Biocidal Textiles for Active Infection Control

Award Year / Program / Phase:
2009 / SBIR / Phase II
Award Amount:
$463,713.00
Agency:
NSF
Principal Investigator:
Abstract:
This Small Business Innovation Research Phase II project focuses on the development of patented antimicrobial compounds to provide superior infection control to textiles. 5-10% of patients admitted to hospitals in the US acquire an infection while in hospital. Consequences of hospital-acquired… More

High Performance Antimicrobial Textiles

Award Year / Program / Phase:
2013 / SBIR / Phase I
Award Amount:
$149,616.00
Agency:
DOD
Principal Investigator:
Nina M. Lamba, President – (410) 939-9356
Abstract:
The goal of this Phase I SBIR proposal is to develop and evaluate a new antimicrobial coating to augment infection control in medical care settings. Laboratory and clinical studies have shown that bacteria can survive for weeks on items found in hospital patient rooms. Such items and are believed to… More